Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Pleomorphic liposarcoma: clinical observations and molecular variables.
[pleomorphic liposarcoma]
Pleomorphic
liposarcoma
(
PLS
)
is
a
rare
high
-grade
sarcoma
that
has
lipoblastic
differentiation
.
In
this
study
,
the
authors
evaluated
PLS
natural
history
,
patient
outcomes
,
and
commonly
deregulated
protein
biomarkers
.
Medical
records
from
patients
(
n
=
155
)
who
had
PLS
from
1993
to
2010
were
reviewed
.
Univariate
and
multivariate
analyses
were
conducted
to
identify
independent
prognosticators
.
A
PLS
tissue
microarray
(
TMA
)
(
n
=
56
patient
specimens
)
was
constructed
for
immunohistochemical
analysis
of
molecular
markers
,
and
p
53
gene
sequencing
(
exons
5
-
9
)
was
conducted
.
The
average
patient
age
was
57
years
,
and
the
patients
presented
with
primary
disease
(
n
=
102
)
,
recurrent
disease
(
n
=
16
)
,
and
metastatic
disease
(
n
=
37
)
.
Lower
extremity
was
the
most
common
disease
site
(
40
%
)
,
and
the
average
tumor
size
was
11
cm
.
Complete
follow-up
data
were
available
for
83
patients
,
and
their
median
follow-up
was
22
.
6
months
.
The
5
-
year
disease-
specific
survival
rate
was
53
%
;
and
recurrent
disease
,
unresectability
,
and
microscopic
positive
margins
were
identified
as
predictors
of
a
poor
prognosis
.
Systemic
relapse
(
the
strongest
poor
prognostic
determinant
)
developed
in
35
%
of
patients
with
localized
PLS
.
Immunohistochemical
analysis
revealed
increased
expression
of
peroxisome
proliferator-activated
receptor
gamma
(
an
adipogenic
marker
)
,
B-
cell
leukemia
2
and
survivin
(
survival
factors
)
,
vascular
endothelial
growth
factor
(
an
angiogenic
factor
)
,
matrix
metalloproteinase
2
,
and
other
biomarkers
.
Frequent
loss
of
retinoblastoma
protein
expression
and
high
p
53
mutation
rates
(
approximately
60
%
)
were
observed
.
PLS
is
an
aggressive
,
metastasizing
sarcoma
.
Identifying
ubiquitous
molecular
events
underlying
PLS
progression
is
crucial
for
progress
in
patient
management
and
outcomes
.
Diseases
Validation
Diseases presenting
"vascular endothelial growth factor"
symptom
adrenal incidentaloma
aniridia
coats disease
dedifferentiated liposarcoma
esophageal squamous cell carcinoma
hodgkin lymphoma, classical
inclusion body myositis
krabbe disease
liposarcoma
lymphangioleiomyomatosis
pleomorphic liposarcoma
primary effusion lymphoma
severe combined immunodeficiency
systemic capillary leak syndrome
von hippel-lindau disease
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom